R&D Pipeline
Guided by innovation and internationalization, Fosun Pharma increases its investment in R&D and the introduction of scientific research personnel, enriches its innovative product pipelines, improves its R&D and clinical trial capacities for new drugs, and speeds up the R&D and transformation of innovative technologies and products through diverse and multi-level cooperation models, such as independent R&D, co-development, in-licensing, and in-depth incubation.
Major Drugs under Development
As of December 2025, Fosun Pharma has nearly 70 key innovative drug projects under development (by indication).
-
- 17
- Number of projects of independent small-molecule innovations
-
- 19
- Number of projects of independent biologic drug innovation
-
- 18
- Number of license-in of innovative drugs
-
- 11
- Number of in-house developed biosimilars